[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dermatologicals in Colombia

September 2023 | 25 pages | ID: D722A433B3CEN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Dermatologicals is expected to see higher value growth in 2023 than in the previous year. Value growth is partly being driven by escalating prices and partly by people returning to in-person medical consultations, which lead to more recommendations of products, mainly for antifungals and haemorrhoid treatments.

Euromonitor International's Dermatologicals in Colombia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Dermatologicals market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
DERMATOLOGICALS IN COLOMBIA
KEY DATA FINDINGS
2023 DEVELOPMENTS
Dermatologicals sees revival of growth
Lice treatments growing but not recovered yet
Hair loss OTC options remain popular despite deceleration
PROSPECTS AND OPPORTUNITIES
Different uses drive topical germicidals
Topical antifungals expected to see growth of generics
Bayer introduces Mexsana Medical
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2018-2023
Table 2 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 4 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2020-2023
Table 6 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN COLOMBIA
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 9 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2018-2023
Table 11 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 12 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 13 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format: % Value 2018-2023
Table 16 Distribution of Consumer Health by Format and Category: % Value 2023
Table 17 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources


More Publications